Hyperopic laser in situ keratomileusis: primary and secondary treatments are safe and effective

Cornea
R Y Choi, S E Wilson

Abstract

To retrospectively analyze the safety and efficacy of hyperopic laser in situ keratomileusis (LASIK) treatment of eyes with primary hyperopia and consecutive hyperopia after initial myopic treatment. Thirty-two eyes of 19 patients with primary hyperopia (group 1) and 37 eyes of 26 patients with consecutive hyperopia after initial myopic LASIK overcorrection (group 2) that had LASIK for hyperopia with the Hansatome microkeratome and VISX S2 Smoothscan excimer laser with 6 months' follow-up after surgery were analyzed. Uncorrected visual acuity, best spectacle-corrected visual acuity, fogged manifest refraction, and corneal topography with corneal irregularity measurement (CIM) were evaluated 1 month, 3 months, and 6 months after surgery. In group 1, the mean preoperative cycloplegic spherical equivalent was +4.0 +/- 4.5 diopters (D) (range, +1.5 to + 8.75 D) and the 6-month postoperative cycloplegic spherical equivalent was +0.26 +/- 1.74 D (range, -3.00 to +2.75 D). Fifty-three percent of eyes (n= 17) in group 1 were within 1 D of emmetropia. Sixty-six percent of eyes (n= 21) had uncorrected visual acuity of at least 20/40. Three eyes (9%) lost two lines of best spectacle-corrected visual acuity. Changes in uncorrected visual a...Continue Reading

References

Jan 1, 1994·Ophthalmology·S E Wilson, S D Klyce
May 1, 1997·Journal of Cataract and Refractive Surgery·W B JacksonE J Casson
Mar 12, 1998·Journal of Cataract and Refractive Surgery·T Kohnen

❮ Previous
Next ❯

Citations

Jan 5, 2002·Journal of Clinical Laser Medicine & Surgery
Jul 31, 2003·Current Opinion in Ophthalmology·Bo Huang
Apr 20, 2010·Clinical & Experimental Ophthalmology·Gerard L Sutton, Peter Kim
Mar 8, 2012·International Ophthalmology Clinics·Zale D Mednick, Guillermo Rocha
May 10, 2017·Journal of Refractive Surgery·Dan Z ReinsteinTara Moore
Apr 11, 2003·Journal of Cataract and Refractive Surgery·Wolfgang E PhilippWolfgang Göttinger
Jun 5, 2003·Journal of Cataract and Refractive Surgery·W Andrew Lyle, George J C Jin
Jul 29, 2008·Journal of Cataract and Refractive Surgery·Simon R BababeygyEdward E Manche
Feb 5, 2013·Journal of Cataract and Refractive Surgery·Jorge L AlióJaime Javaloy
Jun 25, 2005·Journal of Cataract and Refractive Surgery·Peter KimChris Hodge
Nov 1, 2002·International Ophthalmology Clinics·Stephen D Klyce, Michael J Endl
May 19, 2005·Journal of Cataract and Refractive Surgery·George J C JinKevin H Merkley
Oct 23, 2004·Eye & Contact Lens·James E McDonaldDavid Deitz
Feb 25, 2014·ISRN Ophthalmology·Carmina Franz G QuitoRaymond P Evangelista
Nov 8, 2003·Journal of Cataract and Refractive Surgery·Julián García-FeijoóJulián García-Sánchez
Jun 5, 2004·Journal of Cataract and Refractive Surgery·Richard L NepomucenoMichelle Sato
Jun 24, 2009·Journal of Cataract and Refractive Surgery·Fernando LlovetJulio Baviera
Feb 13, 2003·Ophthalmology·Denise FreitasRubens Belfort
Apr 28, 2004·Survey of Ophthalmology·Margaret A ChangDimitri T Azar
Aug 4, 2004·Ophthalmology·Gary A VarleyUNKNOWN Ophthalmic Technology Assessment Committee Refractive Surgery Panel, Ameican Academy of Ophthalmology
Jul 5, 2006·Survey of Ophthalmology·Salomon EsquenaziOlga Bibas
May 25, 2006·Experimental Eye Research·William J Dupps, Steven E Wilson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.